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Introduction
The ratio of the lung cancer (LC) prevalence among women and 
men declined from 1:5-1:4 to 1:2, what is more, this frequency rate 
distribution is decreasing annually.1 The LC incidence among women 
increased by more than three times in the past decade,2 they have also 
increased mortality rates.3 The proportion of the LC prevalence in the 
world is projected to rise in favor of increasing the number of women 
and reducing men by 2020.4 There is a belief that the LC prevalence 
will be approximately the same in the representatives of different sex 
in some regions of the globe in the near future.5 
Sexual dimorphism of the LC course is observed alongside with the 
number of sick women increase,6,7 the female sex is an unfavorable 
risk factor,8 while the male sex is a prognosis negative predictive 
factor for the frequency and severity of the skeleton metastasis.9 
However, according to YF He et al.,10 MF Oliveira et al.,11 there 
are no gender specific features of the so-called “bone” form of LC. 
In recent years there has been a redistribution of the LC frequency in 
groups of different sexes according to the histological variants of the 
disease.6,12 And if among all LC patients 5-year survival is about 
10% now, then in women group this figure is significantly worse.13,14 
It should be noted that the annual mortality from LC among men 
increases on average of 6%, then among women - of 16%.15
The aim of this study was to evaluate the sexual dimorphism of the 
LC clinical course.
Material and methods
The research was carried out in accordance with the ethical norms 
set forth in the Helsinki Medical Assembly Declaration; the patients 
gave informed consent for the study, which was approved by the 
bioethics commission of Donetsk National Medical University. There 
were 1071 LC patients under observation at the National Cancer 
Institute (Kiev) from 2000 to 2015, which were included in the main 
object of the study. Among these patients there were 887 (82.8%) men 
and 184 (17.2%) women, at the age of 59.7 ± 0.32 and 57.0 ± 0.89 
years, respectively (the age of men was significantly higher - t = 3.27, 
p = 0.001). None of the LC patients had previously been operated on, 
and after the diagnosis, all patients received radiotherapy, and 73.1% 
of them had combined radiotherapy. The grade of tumor differentiation 
(GDT) and its stage (STT) was evaluated, the integral index of the 
tumor process severity (ITS) was calculated according to the formula:
  ITS = ln [ T + N2 + (ΣM)2],
where ln is the decimal logarithm, T is the international indicator 
of the primary tumor nature, N is the international metastatic index 
of gional lymph nodes,15,16 ΣМ is the metastase sum in distant organs.
Diagnosis of LC and its metastases was based on clinical, 
radiological (X-ray, computer tomography, sonographic, PET), 
fibroscopic, cytological (histological) methods of investigation. For the 
diagnosing of the disease we used such apparatus as: Multix-Compact-
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Abstract
Introduction: In recent years there has been a redistribution of the lung cancer (LC) 
frequency in groups of different sexes according to the histological variants, localization of 
the disease and dissemination.
Aim: to evaluate the sexual dimorphism of the lung cancer (LC) clinical course, to reveal 
peculiarities of lung cancer clinical course in woman comparing with men.
Patients and methods: there were 1071 LC patients under observation at the National 
Cancer Institute (Kyiv) from 2000 to 2015, which were included in the main object of the 
study. Among these patients there were 887 (82.8%) men and 184 (17.2%) women, at the 
age of 59.7±0.32 years and 57.0±0.89 years, respectively.
Results: The patients’ sex has an effect on the integral parameters of the LC course, the 
localization of the tumor process and the nature of the complications. The side of the lung 
lesions, localization in lobes, the form of the disease, the histological variant of LC and 
its staging, the development of small cell cancer, adenocarcinoma and squamous cell 
carcinoma depend on the sex of the patients. Women had more often middle lobe right 
lung lesion and upper lobe localization of both lungs. Women were 52% more likely to 
have IV lung cancer stage; the germination of LC in the ribs was not observed in women at 
all, and the compression syndrome and tracheal injury accordingly appeared less often at 
52% and 72%, whereas pleurisy was observed 2.2 times more often. Metastasis in women 
was observed 27 times more often in the thyroid gland, 16.5 times - in the abdominal wall, 
2.2 times - in the brain. The metastatic lesion of the skeleton (the so-called “bone form of 
the LC”) was the prerogative of women. Adenocarcinoma of the upper lobe diagnosed in 
women 2.2 times more often, and squamous cell carcinoma - 2 times less often. Female sex 
has an effect on metastases in the mediastinal and inguinal lymphatic nodes, lung, thyroid 
and spine. The gender parameters of survival in men and women were the same.
Conclusions: the course of the LC in woman has its own dimorphism, which is a risk factor 
for a severe tumorous process.
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Siemens (Germany), Somazom-Emotion-6-Siemens (Germany), 
Gygoscan-Intera-Philips (Netherlands), the cyclotron Siemens-RDS-
Eclipse-RD (Germany), combined tomography PET/CT «Biograph-
64-TruePoint-Siemens (Germany), fibroesophagogastroscope» 
Olympus-GIF-Q20 «(Japan) and sonographer « Envisor-Philips 
«(Netherlands). Statistical processing of the obtained results was 
performed using computer variance, nonparametric, correlation, 
regression, single (ANOVA) and multivariate (ANOVA / MANOVA) 
dispersion analysis (“Microsoft Excel” and “Statistica-Stat-Soft”, USA 
programs). We estimated the average values  (M), their standard errors 
and deviations (SD), the parametric correlation coefficients of Pearson 
and the nonparametric of Kendall, the criteria of Brown-Forsythe and 
Wilcoxon-Rao dispersion, Student and McNemar-Fisher’s test, and 
the reliability of the statistical indices. The critical significance level 
for checking the statistical hypotheses was considered to be 0,05 in 
this study.
Results
The upper lobes localization of the lung lesion was established in 
27.0% of cases, the lower lobe - in 15.3%, the upper lower localization 
on the left - in 18.7%, the upper middle - in 25.0%, the lower middle 
- in 1.4%, the middle lobe - in 3.7%. The mediastinal variant of the 
disease was noted in 8.9% of the patients’ number, and in 1.2% of men 
the apex tumor of Pancoast-Tobias was diagnosed. The central form 
of LC was noted in 78.7% of the examined patients, the peripheral - 
in 21.3%, small-cell histological variant of the disease was detected 
in 17.6% of cases, and non-small cell - in 82.5% (adenocarcinoma, 
squamous and large cell carcinoma in the ratio 3: 3: 1). The ratio IA-
ІВ, ІІА-ІІВ, ІІІА, ІІІВ and IV stages of the disease was 1: 2: 23: 35: 
36. GDT was 1.19 ± 0.038 points, STT was 5.87 ± 0.032 r.u., ITS was 
2.85 ± 0.024 r.u. 
According to Wilcoxon-Rao multivariate analysis of variance, the 
patients’ sex has an effect (p <0.001) on the integrated parameters of 
LC course (WR = 33.62), tumor side (WR = 38.89) and the nature of 
complications (WR = 4.41). As evidenced by a single-factor variance 
analysis, the side of the lung lesions (D = 10,44), the localization in 
lobe (D = 10,17), the form of the disease (D = 102,10), the histological 
variant of LC (D = 12.47) and its staging (D = 4.80), as well as the 
development of small cell cancer (D = 12.16), adenocarcinoma (D = 
81.92) and squamous cell carcinoma (D = 36.23) depend on patients’ 
sex.
The bilateral process occurred only in men group. In general, 
gender specificities related to the tumor lesion side (χ2=14,45, 
р=0,001), and, as McNamara-Fisher non-parametric analysis shows, 
in men 64% more often observed left-sided LC (χ2=16, 76, p<0,001), 
whereas in women - 31% more often the right lung was affected 
(χ2=19,49, p<0,001). As can be seen from Table 1, in men: the upper 
lower lobe left lung lesion was observed 4 times more often (χ2=25,64, 
p<0,001) and 3 times the mediastinal form of LC (χ2=9,27, p=0,002), 
and in women in 2,6 times more often detected a lesion of the middle 
lobe (χ2=9,27, p=0,002), by 72% upper lobe localization of both lungs 
(χ2=23,12, p<0,001) and 41% lower lobe (χ2=3,94, p=0,047).
Table 1 Gender differences in the different LC localization and histological variant 
Indices
Sex
Differences
men (n=887) women(n=184)
abs. % abs. % χ2 p
Lesion side:
right 505 56,9 137 74,5 19,49 <0,001
left 370 41,7 47 25,5 16,76 <0,001
bilateral 12 1,4 - - 2,52 0,113
Lesion localization:
upper lobe 213 24,0 76 41,3 23,12 <0,001
middle lobe 26 2,9 14 7,6 9,27 0,002
lower lobe 127 14,3 37 20,1 3,94 0,047
upper lower lobe 190 21,4 10 5,4 25,64 <0,001
middle upper lobe 227 25,6 41 22,3 0,89 0,346
middle lower lobe 15 1,7 - - 3,16 0,076
mediastinal 89 10,0 6 3,3 8,65 0,003
Histological form:
small celled 172 19,4 16 8,7 12,05 0,001
adenocarcinoma 292 32,9 124 67,4 76,23 <0,001
squamous 331 37,3 27 14,7 35,11 <0,001
large cell 92 10,4 17 9,2 0,21 0,644
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In the men’s group, the ratio of small cell and non-small cell lung 
cancer was 1: 4, and among female patients - 11: 1 (χ2=12,05, p=0,001). 
Sexual dimorphism is 2.5 times more often in the development of 
squamous cell carcinoma in men (χ2=35,11, p<0,001) and 2.1 times 
more rarely in the formation of adenocarcinoma (χ2=76,23, p<0,001), 
which is reflected in Table 1 and in Figure 1. The ratio of the central to 
the peripheral form of LC in the male group was 5: 1, and in women 
as 1: 1 (χ2=93,37, p<0,001).
Figure 1 Distribution of patients with different sex according to histological forms of LC.
Note. SC - small cell LC, NSC - non-small cell LC, AC - adenocarcinoma, SCC - squamous cell carcinoma, LCC- large cell carcinoma.
Discussion
The gender specific features of LC are caused by complex influences 
on the pathological process of developing hypoestrogenemia in 
postmenopausal women and the estrogen / androgen imbalance 
in men,17 inhibition of estrogen receptions.18 Certain significance 
is attached to mutations of some genes in lung adenocarcinoma, 
which is observed in 9% of the sick women number and only 3% 
of men.19 There is sexual dimorphism with respect to the staging of 
LC (χ2=23,41, p=0,001). For example, in men, IIIB STT (χ2=16,98, 
p<0,001) was 2.2 times more often, and in women IV STT occurred 
by 52% (χ2=19,05, p<0,001). These data are presented in Figure 2. 
As can be seen from Table 2, the average GDT and ITS in men and 
women differ little from each other (correspondingly, 1.16 ± 0.041 
points and 1.34±0.100 points, 2.84±0.026 r.u. and 2.94±0.062 r.u.), 
while STT values in women were significantly higher (5.84±0.034 r.u. 
and 6.03±0.022 r.u., t = 2.25, p = 0.025).
Table 2 Gender features of the metastases number in LC patients 
Metastases  localization
Sex Differences
men (n=887) women (n=184) t p
In lymph nodes 1,59±0,034 1,47±0,067 1,42 0,157
In distant organs 1,34±0,039 1,44±0,102 1,13 0,262
In skeleton 1,92±0,089 2,32±0,168 2,28 0,024
According to ANOVA, the sex of patients affects the exudative 
pleurisy development (D = 18,20, p <0,001), tumor germination in 
the trachea (D = 8,00, p = 0,005) and ribs (D = 5,77, p = 0,017 ), as 
well as on the appearance of compression syndrome (D = 3.99, p = 
0.046), which is shown in Figure 3. Germination of the LC into the 
ribs was not observed in women at all, and compression syndrome 
and tracheal injury respectively appeared less frequently by 52% and 
72%, whereas pleurisy was observed 2.2 times more often.
According to the performed ANOVA / MANOVA we had such 
results as: the sex of LC patients has a highly significant (p <0.001) 
effect on the metastases character in the lymph nodes (WR = 6.03, 
p <0.001), distant organs (WR = 4.12) and osteoarticular apparatus 
(WR = 4.51). According to ANOVA, the number of metastases to 
distant organs (D = 2.96, p = 0.019) and the skeleton (D = 8.31, p 
<0.001) depends on the patients’ sex. Bone and joint metastases had 
16+5 (18.5%) men and 69 (37.5%) women (χ2=32,25, p<0,001) and 
the mean number of LC metastases in the skeleton in women was 21% 
more often (t = 2.28, p = 0.024), which is shown in Table 3.
As can be seen from Table 4, the patients’ sex affects the frequency 
of metastases development in the mediastinal, inguinal and subclavian 
lymph nodes.
In the women group LC dissemination to the kidney was never 
observed, whereas it was noted in 15 (2.1%) of men (χ2=4,01, 
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р=0,045), which is reflected in Table 5. In turn, sexual dimorphism 
of the disease manifested more frequent (by 27 times) development 
of metastases in the thyroid (χ2=18,56, p<0,001), in 16,5 times more 
often in the abdominal wall (2=18,94, p<0,001), 2.2 times - in the brain 
(χ2=12,03, p=0,001). The metastatic lesion of the skeleton (the so-
called “bone form of the LC”) was the prerogative of women (Table 
5). Thus, if the metastases to the femoral bone appeared 3.7 times 
more often in the male group (χ2=3,93, p=0,047), then the incidence of 
metastasis in the ribs predominated in women (1.9 times more often, 
χ2=7,57, p=0,006), 4.1 times in the scapula (χ2=7,76, p=0,005), 2.5 
times in the cervicothoracic and lumbar spine (χ2=28,07, p<0,001), 
4.2 times in the sacral region (χ2=27,09, p<0,001), 4.5 times in the 
pubic bone (χ2=7,64, p=0,006), 3.8 times in the iliac bone (χ2=29,71, 
p<0,001), 4.1 times in the sacroiliac joint (χ2=19,13, p<0,001), 2.4 
times in the hip joints (χ2=6,24, p=0,013), and the jaw lesion took 
place only in women (χ2=14,51, p<0,001). In the group of women, 
the gender features of the LC course were as follows. The LC form 
(central, peripheral) affected the appearance of obturation atelectasis 
(D = 5.20, p = 0.024), compression of the superior vena cava (D = 
4.78, p = 0.030), metastasis to supraclavicular (D = 6.53, p = 0.011) 
and cervical lymph nodes (D =6.96, p=0.009); localization of the 
tumor process influenced the germination in the trachea (D =8.23, 
p=0.005), ileac metastasis (D = 17.60, p<0.00) and sacrum bone 
(D = 9.57, p = 0.002); squamous cell carcinoma of LC affects the 
recurrent nerve compression (D = 8.74, p = 0.004), development of 
metastases in the pubic bone (D=4.52, p=0.035); large cell carcinoma 
contribute to tumor germination into the esophagus (D = 22.03, 
p <0.001) and dissemination into the humeral bone (D = 4.35, p = 
0.038); and adenocarcinoma - into the femur (D = 4.09, p = 0.045). 
Gender parameters of the patients’ survival were the same in men and 
women, and 3-year survival rate was respectively 24% and 25%. As 
shown by ANOVA, sexual dimorphism LC was characterized by a 
significant effect of the pathological process localization in men on 
the life duration (D = 1.47, p = 0.026), the form of the disease (D = 
1.41, p=0.042), the presence of exudative tumoral pleurisy (D = 2.55, 
p <0.001), tumor germination into the trachea (D=1.51, p=0.018), 
esophagus (D = 1.53, p = 0.015) and chest wall (D = 2.08, p <0.001 
(D = 3.69, p<0.001), and in women - small cell variant of LC (D=3,69, 
p<0,001), compression syndrome (D=3.02, p<0.001), and obturation 
atelectasis (D =4.90, p<0.001). 
Figure 2 Distribution of different sexes patients by stages of LC.
Note. Left - men, right - women.
Table 3 Gender features of the lymph nodes metastases frequency in LC patients
Lymph node  groups
Sex
Differences
men (n=887) women (n=184)
abs. % abs. % χ2 р
Mediastinal 630 71,0 89 48,4 35,45 <0,001
Supraclavicular 145 16,4 35 29,0 0,78 0,377
Subclavian 13 1,5 9 4,9 8,89 0,003
Cervical 62 7,0 15 8,2 0,31 0,579
Axillary 23 2,6 6 3,3 0,26 0,612
Submandibular 6 0,7 - - 1,25 0,263
Bronchopulmonary 190 21,4 29 15,8 3,00 0,083
Bifurcation 54 6,1 6 3,3 2,30 0,129
Inguinal 4 0,5 7 3,8 16,86 <0,001
Mesenterial 11 1,2 1 0,5 0,67 0,414
Retroperitoneal 19 2,1 2 1,1 0,88 0,348
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Table 4 Gender features of the distant organ metastases frequency  in the LC patients
Organs
Sex
Differences
men (n=887) women (n=184)
abs. % abs. % χ2 р
Lung 128 14,4 35 19,0 2,49 0,115
Skin 11 1,2 5 2,7 2,26 0,133
Thyroid 1 0,1 5 2,7 18,56 <0,001
Aorta 9 1,0 - - 1,88 0,170
Heart 13 1,5 - - 2,73 0,099
Brain 55 6,2 25 13,6 12,03 0,001
Eye - - 2 1,1 9,66 0,002
Kidney 15 2,1 - - 4,01 0,045
Adrenal 31 2,5 5 2,7 0,28 0,594
Abdominal wall 2 0,2 6 3,3 18,94 <0,001
Liver 77 8,7 16 8,7 0,01 0,995
Intestine 7 0,8 - - 1,46 0,227
Pancreas 14 1,6 3 1,6 0,01 0,959
Table 5 Gender features of the metastases frequency in the osteo-articular apparatus in LC patients
Bones, joints
Sex
Differences
men (n=887) women (n=184)
abs. % abs. % χ2 р
Skull 4 0,5 - - 0,83 0,361
Sternum 11 1,2 2 1,1 0,03 0,863
Ribs 55 6,2 22 12,0 7,57 0,006
Jaws - - 3 1,6 14,51 <0,001
Clavicles 8 0,9 2 1,1 0,06 0,812
Scapula 7 0,8 6 3,3 7,76 0,005
Elbow joints 3 0,3 - - 0,62 0,430
Humeral bones 21 2,4 5 2,7 0,08 0,779
Shoulder joints 15 1,7 4 2,2 0,20 0,652
Knee joints 2 0,2 - - 0,42 0,519
Spine 78 8,8 41 22,3 28,07 <0,001
Pubic bone 5 0,6 5 2,7 7,64 0,006
Ilium 30 3,4 24 13,0 29,71 <0,001
Sacrum 23 2,6 20 10,9 27,09 <0,001
Sacral-ileal joints 18 2,0 15 8,2 19,13 <0,001
Femur bones 36 4,1 2 1,1 3,93 0,047
Hip joints 22 2,5 11 6,0 6,24 0,013
Tibias 8 0,9 - - 1,67 0,196
Ankle joints 2 0,2 - - 0,42 0,519
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Figure 3 Gender features of LC clinical manifestations.
Note. 1 - exudative pleurisy, 2 - tumor germination in the trachea, 3 - tumor germination in the ribs, 4 - compression syndrome, 5 - compression of the superior 
vena cava, 6 - mediastinum lesion, 7 - tumor germination in the esophagus, 8 - obturation atelectasis, 9 - tumor germination in the pericardium, 10 - tumor 
germination in the thoracic wall, 11 - compression of the recurrent nerve.
The gender features of the upper lobe LC were further analyzed, 
in which the sexual dimorphism of this localization is noted in the 
literature.6,7 All patients suffering from large cell carcinoma in the 
upper lobes turned out to be males, whereas adenocarcinoma was 2.2 
times more often diagnosed in women, and squamous cell carcinoma 
was 2 times less frequent (χ2=108,92, p<0,001). Sexual dimorphism 
is absent in relation to regional complications of the disease and the 
nature of metastasis in the lymph nodes. In women, only exudative 
pleurisy (11.1% of LC cases) occurred and in 1 case, the tumor 
dissemination into the chest wall. According to ANOVA, the patients’ 
sex affects metastases in the mediastinal and inguinal lymph nodes (D 
= 3.29, p = 0.039 and D = 6.27, p = 0.013, respectively), lung (D = 
6.71, p = 0.010), the thyroid gland (D = 12.90, p <0.001) and the spine 
(D = 23.53, p <0.001), which is the prerogative of women.
We considered it appropriate to further study the nature of the upper 
lobe adenocarcinoma course, as the most frequent variant of LC in 
women. The differentiation degree of this tumor in representatives of 
different sexes differed little among themselves (t = 1.35, p = 0.185). 
The number of distant metastases (D = 3.78, p = 0.013), the presence 
of metastases in the cervical lymph nodes (D = 5.20, p = 0.025), 
the spine (D = 10.21, p = 0.002) and lungs (D = 5.58, p = 0.020) 
depended on the patients’ sex. The last three metastases localizations 
were detected in women 8.2 times (χ2=5,05), 3.5 times (χ2=9,47) and 
2.8 times (χ2=5,39) more often.
Conclusion
There are gender specific features of the LC course, which are 
related to the localization of the pathological process (in men more 
often on the left and in the mediastinum, in women - on the right, 
locally in the upper, middle and lower lobes), to STT parameters 
in the manifest of the disease (in women the level is higher), tumor 
form (prevalence of central in men and peripheral in women), the 
frequency of squamous cell carcinoma in men and adenocarcinoma in 
women, metastasis presence in the mediastinal lymph nodes, kidneys, 
femur, subclavian, inguinal lymph nodes, thyroid gland, brain, eyes, 
abdominal wall, jaw, clavicle, spine, pubic, sacral, iliac, sacroiliac and 
hip joints in others, sexual dimorphism of patients’ survival is absent. 
There are the gender peculiarities of the upper lobe LC course: more 
frequent development of small cell and squamous cell carcinomas in 
men, but less degree of differentiation of the tumor process, and in 
women - adenocarcinoma, absence of Pancoast-Tobias cancer, large 
cell carcinoma, greater frequency of distant metastases (in the lung, 
spine), as well as STT of adenocarcinoma, while there are no gender 
specific features of survival of patients with such a localization of LC.
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